Simplex Trading
RETA

Simplex Trading’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Simplex Trading’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17,884
Closed -$2.69M – 10249
2023
Q2 		$1.82M Buy
17,884
+6,143
+52% +$581K ﹤0.01% 2036
2023
Q1 		$1.07M Sell
11,741
-4,009
-25% -$235K ﹤0.01% 2536
2022
Q4 		$598K Buy
15,750
+2,700
+21% +$92.9K ﹤0.01% 2992
2022
Q3 		$327K Sell
13,050
-858
-6% -$23.8K ﹤0.01% 3979
2022
Q2 		$422K Buy
13,908
+858
+7% +$25.6K ﹤0.01% 3661
2022
Q1 		$427K Sell
13,050
-24,100
-65% -$715K ﹤0.01% 4037
2021
Q4 		$979K Buy
+37,150
New +$2.87M ﹤0.01% 2876
2017
Q4 		– Sell
-100
Closed -$2.79K – 6903
2017
Q3 		$3K Buy
+100
New +$3.01K ﹤0.01% 4900

Simplex Trading's RETA Position: Q3 2023 in Review

Simplex Trading sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 17,884 shares — an estimated $2.69M sold.

Simplex Trading first reported a position in RETA in Q3 2017 and held it in 8 quarters. The position peaked at $1.82M in Q2 2023. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

  • Simplex Trading reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Simplex Trading sold 17,884 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $2.69M.
  • Simplex Trading first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2017 and held it in 8 quarters.
  • Simplex Trading's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $1.82M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.